ERAS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jun 2024 @ 11:49):
Our systems believe the stock currently is undervalued by 0.03% compare to its pairs and should correct upwards.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers...

Stats
Today's Volume	755 631
Average Volume	1.68M
Market Cap	533.98M
EPS	$-0.230 ( Q1 \| 2024-05-08 )
Next earnings date	( $-0.170 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.45 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00700 (0.34%)

AADI -2.65%

ABCL 2.20%

ABCM 0.04%

ABEO -1.90%

ABIO -1.69%

ABOS 0.00%

ABSI 2.04%

ABUS -2.29%

ABVX -2.03%

ACAD -0.48%

ACER -17.95%

ACET -5.12%

ACGN 1.29%

ACHL -2.20%

ACHV -1.29%

ACIU -1.50%

ACLX 0.22%

ACRV -5.28%

ACST -3.58%

ACXP 1.38%

ADAG 4.64%

ADAP -4.68%

ADGI 0.87%

ADIL 0.54%

ADMA -2.72%

ADPT 0.30%

ADTX -3.47%

ADVM -3.33%

ADXN -1.60%

AEON -3.74%

AEZS -2.49%

AFMD -1.22%

AGEN -2.56%

AGIO -2.48%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -1.74%

AKRO -2.34%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC -1.15%

ALGS -2.31%

ALKS -0.08%

ALLK -8.90%

ALLO -4.58%

ALLR -3.37%

ALNA 3.16%

ALNY 2.14%

ALPN 0.02%

ALPX 0.00%

ALRN 0.33%

ALT -9.65%

ALVR 2.32%

ALXN 0.00%

ALXO -11.19%

ALZN 1.97%

AMRN -0.73%

AMTI -3.13%

ANAB 0.84%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -1.53%

ANPC -3.15%

APGE -1.04%

APGN 8.48%

APGNW 30.65%

APLM -6.47%

APLS 0.99%

APLT -3.83%

APM -2.94%

APOP 0.38%

APRE 0.60%

APTO 6.30%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.23%

ARDS -14.23%

ARDX -0.17%

ARGX -1.09%

ARNA 0.00%

ARPO -0.90%

ARQT -1.15%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.56%

ARWR -1.67%

ASLN -5.07%

ASMB -8.31%

ASND -1.27%

ATAI -1.11%

ATHA 5.48%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 0.97%

ATRA -2.83%

ATXI 1.93%

ATXS -0.33%

AUPH -0.81%

AURA 1.91%

AUTL -1.58%

AVBP -4.23%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -4.14%

AVTX -1.25%

AVXL -2.96%

AXLA 0.00%

AXSM -1.27%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.59%

BCAB 4.61%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 5.82%

BCRX 1.40%

BCTX 8.16%

BCTXW -16.32%

BCYC 1.30%

BDRX -4.94%

BDTX -1.07%

BEAM 0.95%

BFRA -2.91%

BGNE -3.12%

BIOR -5.21%

BIVI 3.89%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.62%

BLU 0.03%

BLUE -0.23%

BMEA -11.41%

BMRN 0.55%

BNOX 4.61%

BNTC -0.42%

BNTX -1.87%

BOLD -8.47%

BOLT 0.72%

BPMC -0.99%

BPTH 1.42%

BPTS -13.47%

BRNS -0.74%

BRTX -2.36%

BTAI 28.81%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.39%

CABA 1.28%

CADL -1.31%

CALA 0.00%

CALC -1.77%

CALT -1.14%

CAPR -2.80%

CARA 0.72%

CARM 11.30%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -6.39%

CCCC -5.31%

CCXI 0.00%

CDAK 0.00%

CDIO -2.20%

CDIOW 24.00%

CDMO -2.81%

CDMOP 0.04%

CDT -12.24%

CDTTW -39.60%

CDTX -1.92%

CDXC 0.83%

CDXS 7.24%

CELC -3.94%

CELU -1.97%

CELUW 11.80%

CERC -1.68%

CERE -0.94%

CERO -4.50%

CEROW -22.75%

CFRX -27.95%

CGEM -2.50%

CGEN -3.31%

CGON -0.83%

CGTX -4.79%

CHMA -6.00%

CHRS 0.63%

CINC 0.00%

CING -2.71%

CINGW 34.95%

CKPT -3.35%

CLBS -16.75%

CLDX -2.02%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 8.15%

CLSD 0.43%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 2.42%

CMPI 0.00%

CMPX -7.55%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.04%

CNCE 0.00%

CNSP -35.88%

CNST 0.00%

CNTA -0.67%

CNTB 0.00%

CNTX -6.85%

COCP -2.00%

COEPW 32.45%

COGT -2.28%

CORT 2.20%

COYA -1.46%

CPRX -1.06%

CRBP -3.09%

CRBU -4.83%

CRDF -0.89%

CRGX 0.74%

CRIS -0.38%

CRNX -5.87%

CRSP 1.18%

CRTX 2.63%

CRVO -4.15%

CRVS 1.82%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -2.90%

CTNM -1.35%

CTXR 1.09%

CUE 3.81%

CVAC -2.54%

CVKD 0.10%

CWBR 2.80%

CYAD -12.96%

CYCC 8.03%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -1.61%

CYTO -2.70%

DARE 6.41%

DAWN 0.63%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 26.99%

DNLI -1.12%

DNTH -9.22%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.11%

DTIL 0.56%

DYAI 10.32%

EARS -1.77%

EDIT -2.52%

EDSA 3.19%

EFTR 4.25%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.56%

ELEV -5.81%

ELOX 7.69%

ELTX -0.88%

ELVN -4.35%

ELYM 2.30%

ENGN -3.45%

ENGNW 0.00%

ENLV 2.54%

ENOB 1.79%

ENSC 5.16%

ENTA -0.57%

ENTO -2.42%

ENTX 2.08%

ENVB 1.42%

EPIX -0.31%

EPRX -2.97%

EPZM 0.00%

EQ 0.32%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.20%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON 2.13%

ETTX 0.00%

EVAX -2.14%

EVGN 3.97%

EVLO 0.00%

EWTX 0.06%

EXAI -0.57%

EXEL -0.20%

EYEG -0.69%

EYEN 0.43%

EYPT 0.97%

FATE -7.39%

FBIO 0.89%

FBIOP 0.92%

FBLG -15.40%

FBRX -0.04%

FDMT -3.82%

FENC -1.29%

FGEN -4.70%

FHTX 1.72%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.23%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.18%

FULC -3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -4.19%

GHRS -2.13%

GLMD -5.09%

GLPG -2.26%

GLSI 1.69%

GLTO -0.57%

GLUE -2.51%

GLYC -10.15%

GMAB -0.60%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.65%

GNLX 1.11%

GNPX 0.98%

GNTA 3.94%

GOSS -11.65%

GOVX 5.02%

GOVXW -49.04%

GPCR -6.82%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.32%

GRTX 2.57%

GTHX 0.91%

GUTS -5.31%

GXGXW 41.67%

GYRE -6.10%

HALO -1.49%

HARP 0.09%

HCWB -3.75%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX 0.08%

HOOK -0.77%

HOTH -2.70%

HOWL -2.78%

HRMY 0.37%

HRTX 4.27%

HSTO 0.00%

HUMA 0.30%

HUMAW -0.01%

IBRX -3.85%

ICCC 0.22%

ICPT 0.21%

ICU 18.56%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.55%

IFRX -1.85%

IGMS -0.44%

IKNA 1.19%

IKT 1.42%

IMAB 0.00%

IMCR -2.99%

IMGN 0.02%

IMGO 0.00%

IMMP 6.08%

IMMX -7.33%

IMNM -1.78%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.35%

IMTX -1.67%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.70%

INAB -0.01%

INBX 0.43%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 2.31%

INMB 1.95%

INO -2.47%

INSM -1.32%

INTS -2.75%

INVA 0.34%

INZY 1.03%

IOBT -11.02%

IONS 0.30%

IOVA -1.83%

IPA 0.00%

IPHA 5.58%

IPSC -1.95%

IRON -2.68%

ISEE 0.38%

ITOS -1.90%

ITRM 1.67%

IVA 6.96%

IVVD -2.48%

JAGX 1.84%

JANX -3.57%

JAZZ -0.70%

JNCE 0.00%

JSPR -5.98%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -1.52%

KDNY 0.22%

KMPH -0.34%

KNSA -2.64%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -2.29%

KRBP -10.00%

KRON 1.05%

KROS -1.40%

KRRO -8.20%

KRTX 0.03%

KRYS -0.86%

KTRA 15.65%

KTTA 8.16%

KTTAW 0.92%

KURA -1.12%

KYMR -2.28%

KYTX -3.75%

KZIA 2.65%

KZR -0.93%

LABP 0.57%

LBPH -2.21%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.95%

LENZ -3.84%

LEXX 2.31%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -9.98%

LIAN -8.28%

LIFE 2.70%

LIPO -11.13%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -2.94%

LPTX -1.65%

LQDA -0.79%

LRMR -2.20%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -4.21%

LXRX -1.47%

LYEL -33.58%

LYRA 0.93%

MACK 0.10%

MBIO -11.26%

MBRX -2.57%

MCRB 2.61%

MDGL -2.69%

MDNA -13.16%

MDWD 0.03%

MDXG -2.50%

MEIP -0.13%

MESO -2.08%

MGNX -3.03%

MGTA -7.74%

MGTX -3.33%

MGX -4.83%

MIRM -1.70%

MIRO 0.59%

MIST 0.77%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -1.01%

MLYS -5.91%

MNKD -0.95%

MNMD 0.50%

MNOV 2.11%

MNPR -5.01%

MOLN 1.79%

MOR 1.20%

MORF -2.60%

MREO -3.57%

MRKR 2.68%

MRNA -5.19%

MRNS -4.04%

MRSN -1.90%

MRTX -0.17%

MRUS 0.22%

MRVI -1.97%

MTCR -1.29%

MTEM 4.95%

MTP -18.50%

MURA -0.93%

MYMD 5.41%

NAMS 1.88%

NAMSW 0.43%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.82%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.27%

NKGN 9.24%

NKGNW 8.00%

NKTR -4.21%

NKTX -4.40%

NLSP 8.82%

NLSPW 26.67%

NMRA -3.20%

NMTR -42.97%

NOVN -24.84%

NRBO 12.63%

NRIX -0.24%

NRSN -5.12%

NRSNW 0.00%

NRXP -5.20%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -5.40%

NTRBW -31.07%

NUVL -1.32%

NVAX -2.22%

NVCT 4.51%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 0.26%

OABIW -10.06%

OBIO -4.53%

OBSV 0.00%

OCEA -0.70%

OCGN 3.80%

OCS -1.00%

OCUL -1.37%

OCUP 1.31%

ODT -4.27%

OKYO 1.51%

OLMA -5.88%

OMER -0.51%

OMGA 5.64%

ONCO 4.96%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY -0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 2.06%

ORGS 0.65%

ORIC -3.56%

ORMP 21.43%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.29%

OVID -1.43%

OYST 0.00%

PALI 2.58%

PASG -1.30%

PBLA -7.50%

PBM -8.20%

PBYI 1.35%

PCSA 0.00%

PCVX -0.16%

PDSB -3.64%

PEPG 1.85%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -0.97%

PHIO -0.83%

PHIOW 36.47%

PHVS -6.81%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.20%

PLUR 7.49%

PMN 0.72%

PMVP 0.00%

PNT 0.16%

PPBT -4.68%

PRAX 1.04%

PRDS 0.93%

PRLD -3.17%

PROG -3.47%

PROK -0.45%

PRQR -0.01%

PRTA -2.26%

PRTC 0.49%

PRTG -0.54%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -8.54%

PSTX -0.39%

PTCT -0.46%

PTE -0.82%

PTGX -1.07%

PTIXW -49.04%

PULM 2.60%

PXMD 0.00%

PYPD 0.07%

PYXS 1.31%

QLGN -8.10%

QNCX 5.70%

QNRX 0.37%

QSI -11.97%

QSIAW -3.13%

QTTB -1.42%

QURE -0.78%

RAIN -1.63%

RANI 6.42%

RAPT -2.60%

RARE 1.33%

RCKT -7.67%

REGN -0.26%

RENB -3.42%

REPL -2.72%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 4.38%

RGLS -5.37%

RGNX -5.52%

RIGL -3.29%

RLAY -4.01%

RLMD 0.33%

RLYB -0.67%

RNA 0.33%

RNAC -5.94%

RNAZ -0.96%

RNXT 0.01%

ROIV -1.94%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.24%

RPTX -2.49%

RUBY 2.70%

RVLP -32.05%

RVMD -0.86%

RVMDW -30.00%

RVNC 2.34%

RVPH -1.19%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.30%

RYTM -6.20%

RYZB 0.02%

RZLT 0.78%

SABS -1.37%

SABSW -11.81%

SAGE 1.74%

SANA -3.24%

SAVA -0.60%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH 2.40%

SCPS 0.00%

SEEL -4.74%

SEER 0.59%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO 0.20%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -6.38%

SLGL 2.97%

SLN -4.40%

SLNO -4.12%

SLRX 6.07%

SLS -2.14%

SMMT -2.60%

SNDX 1.54%

SNGX -2.64%

SNPX -3.84%

SONN -1.08%

SPPI -0.49%

SPRB 0.91%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.11%

SRRA 0.00%

SRRK -2.35%

SRZN -2.45%

STAB 0.00%

STOK -4.57%

STRO -2.84%

STSA 0.00%

STTK -0.99%

SURF -0.93%

SVRA -4.61%

SWTX 0.54%

SYBX -1.29%

SYRS -1.03%

TALS -0.73%

TARA -8.10%

TARS -0.21%

TBPH 0.48%

TCBP 2.47%

TCDA 0.00%

TCON 2.74%

TCRR 0.00%

TCRT 1.59%

TCRX 1.45%

TECH -0.10%

TENX 0.32%

TERN -7.59%

TFFP -5.33%

TGTX -2.78%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -2.59%

TNGX -2.59%

TNXP -6.19%

TNYA -4.39%

TPST 2.92%

TRDA -4.64%

TRVI 2.30%

TRVN 2.97%

TSHA -24.75%

TSVT -2.93%

TTNP -7.79%

TVTX 1.01%

TYRA -7.13%

UBX -2.13%

UNCY -3.90%

URGN -1.18%

UTHR -0.28%

VACC 11.36%

VALN -2.89%

VAXX 80.94%

VBIV 0.78%

VBLT -8.77%

VCEL -0.23%

VCNX 10.35%

VCYT -0.88%

VERA -3.48%

VERU -0.72%

VERV -2.77%

VIGL 6.34%

VINC 2.96%

VIR 0.98%

VIRI -1.61%

VIRX 2.40%

VKTX -1.27%

VLON -13.04%

VNDA -2.44%

VOR -2.02%

VRCA 0.00%

VRDN -4.15%

VRNA -1.23%

VRPX 0.38%

VRTX 0.36%

VSTM -0.98%

VTGN -1.05%

VTVT -2.97%

VTYX -1.26%

VXRT -3.78%

VYGR -0.77%

VYNE -4.62%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT -0.42%

XCUR 3.58%

XENE -2.86%

XERS 2.14%

XFOR 2.52%

XLO 4.54%

XLRN 0.00%

XNCR 0.67%

XOMA -2.94%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.63%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.86%

ZNTL -0.48%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-06-20	Varney Michael David	Buy	60 000	Stock Option (right to buy)
2024-06-20	Start Valerie Denise Harding	Buy	60 000	Stock Option (right to buy)
2024-06-20	Liu Jean I	Buy	60 000	Stock Option (right to buy)
2024-06-20	Garner Ebun	Buy	160 082	Stock Option (right to buy)
2024-06-20	Morris Shannon	Buy	137 142	Stock Option (right to buy)

INSIDER POWER
94.48
Last 97 transactions
Buy: 51 526 214 \| Sell: 10 940 033

Correlation (AI algo v.1.1b): Undervalued: 0.03% $2.06 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.28 (neutral)

Short: 0.63 (weak)

Signal:(52.362) Neutral

Erasca, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Erasca, Inc. Correlation - Currency/Commodity

-0.15
( neutral )

-0.40
( neutral )

0.00
( neutral )

0.69
( moderate )

0.00
( neutral )

0.59
( weak )

Erasca, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-3.73M (0.00 %)
EPS:	$-0.830

FY	2023
Revenue:	$0
Gross Profit:	$-3.73M (0.00 %)
EPS:	$-0.830

FY	2022
Revenue:	$0
Gross Profit:	$-2.64M (0.00 %)
EPS:	$-1.950

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-1.790

Financial Reports:

No articles found.

Erasca, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Erasca, Inc.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company\'s lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.